Update shared on 26 Nov 2025
Fair value Increased 15%Analysts have raised their price target for American Healthcare REIT from $48.73 to $56.08. They cite a significantly improved revenue growth outlook, even though profit margin projections have been reduced.
What's in the News
- American Healthcare REIT filed a follow-on equity offering of 8,100,000 shares of common stock (Key Developments)
- The company filed a second follow-on equity offering for 8,100,000 common stock shares with an income trust component (Key Developments)
- The company reported consolidated impairment charges of $3.77 million for the three months ended September 30, 2025, related to real estate investments (Key Developments)
- The company raised full-year 2025 financial guidance, increasing projected net income and portfolio same-store net operating income growth (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has increased from $48.73 to $56.08, reflecting an improved outlook.
- Discount Rate edged up slightly from 7.24 percent to 7.26 percent.
- Revenue Growth projections more than doubled, rising from 5.46 percent to 11.48 percent.
- Net Profit Margin expectations declined from 12.57 percent to 7.35 percent.
- Future P/E ratio estimate climbed sharply from 40.14x to 66.93x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.